Kanser biyolojisindeki son geli\u015fmeler, meme kanseri h\u00fccrelerinin malign fenotiplerini s\u00fcrd\u00fcrmek i\u00e7in ger\u00e7ekle\u015ftirdi\u011fi karma\u015f\u0131k metabolik adaptasyonlar\u0131 anlamada \u00f6nemli ilerlemeler sa\u011flam\u0131\u015ft\u0131r. Bu adaptasyonlar aras\u0131nda lipid metabolizmas\u0131ndaki de\u011fi\u015fiklikler, t\u00fcm\u00f6r b\u00fcy\u00fcmesi, metastaz ve tedaviye yan\u0131t \u00fczerinde kritik bir rol oynamaktad\u0131r. \u00d6zellikle, agresif bir alt t\u00fcr olan \u00fc\u00e7l\u00fc negatif meme kanserinde (TNBC) lipid yolaklar\u0131n\u0131n yeniden programlanmas\u0131, kanser ilerlemesini engellemek ve ila\u00e7 diren\u00e7 mekanizmalar\u0131n\u0131 \u00e7\u00f6zmek ad\u0131na \u00f6nemli f\u0131rsatlar sunmaktad\u0131r.<\/p>\n
Meme kanseri h\u00fccrelerinde g\u00f6r\u00fclen metabolik de\u011fi\u015fimlerin merkezinde, ya\u011f asitlerinin artan h\u00fccre i\u00e7i al\u0131m\u0131 ve de novo sentezi bulunur. H\u0131zla \u00e7o\u011falan kanser h\u00fccrelerinin enerji gereksinimlerini kar\u015f\u0131laman\u0131n \u00f6tesinde, bu s\u00fcre\u00e7ler membran biyogenezi ve sinyal iletiminde kritik yap\u0131 ta\u015flar\u0131 sa\u011flar. Ya\u011f asidi sentez enzimi olan ya\u011f asidi sentaz (FASN) ve ya\u011f asidi ta\u015f\u0131y\u0131c\u0131 proteinleri CD36 ile FABP4’\u00fcn meme t\u00fcm\u00f6r\u00fc h\u00fccrelerinde belirgin bi\u00e7imde a\u015f\u0131r\u0131 eksprese edilmesi, lipid birikimine yol a\u00e7ar. Bu birikim, h\u00fccre membranlar\u0131n\u0131n yeniden \u015fekillenmesini destekleyerek h\u00fccre hareketlili\u011fi ve invazivli\u011fini art\u0131r\u0131r; bu durum metastaz yetene\u011finin \u00f6nemli bir g\u00f6stergesidir.<\/p>\n
Kolesterol metabolizmas\u0131 da meme kanser patobiyolojisinde \u00f6nemli bir eksen olu\u015fturur. Kolesterol biyosentezindeki art\u0131\u015f ve 27-hidroksikolesterol (27HC) seviyelerindeki y\u00fckselme t\u00fcm\u00f6r ilerlemesini h\u0131zland\u0131ran fakt\u00f6rler olarak \u00f6ne \u00e7\u0131kar. 27HC, \u00f6strojen resept\u00f6rleri i\u00e7in bir agonist i\u015flevi g\u00f6r\u00fcrken, t\u00fcm\u00f6r mikroi\u00e7erisindeki ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin davran\u0131\u015f\u0131n\u0131 mod\u00fcle eder. Kolesterol homeostaz\u0131nda g\u00f6rev alan SREBP2, NSDHL ve STARD4 gibi proteinlerin d\u00fczensiz ekspresyonu, malign fenotiplerin peki\u015fmesine ve t\u00fcm\u00f6r ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131ndan ka\u00e7\u0131\u015fa zemin haz\u0131rlar.<\/p>\n
Sfingolipid metabolik a\u011f\u0131, meme kanserinde \u00e7eli\u015fkili fakat \u00f6nemli bir rol oynar. Ceramid birikimi, kanser bask\u0131lay\u0131c\u0131 bir i\u015flev g\u00f6rerek apoptozisi tetikler ve kemoterapiye duyarl\u0131l\u0131\u011f\u0131 art\u0131r\u0131r. Buna kar\u015f\u0131n, glikozile sfingolipid t\u00fcrevleri olan Globo-H ceramid ve GD2, t\u00fcm\u00f6r olu\u015fumu, anjiyogenez ve kanser k\u00f6k h\u00fccrelerinin s\u00fcrd\u00fcr\u00fclmesi ile ili\u015fkilendirilir. Bu durum, lipid arac\u0131l\u0131 sinyal yollar\u0131n\u0131n kanser h\u00fccre kaderini belirlemede ne denli karma\u015f\u0131k ve \u00e7ok y\u00f6nl\u00fc oldu\u011funu g\u00f6sterir.<\/p>\n
Lipid metabolizmas\u0131n\u0131n yeniden programlanmas\u0131n\u0131n \u00f6zellikle y\u0131k\u0131c\u0131 sonu\u00e7lar\u0131ndan biri, epitel-mezenkimal ge\u00e7i\u015fin (EMT) kolayla\u015ft\u0131r\u0131lmas\u0131d\u0131r. EMT, kanser h\u00fccrelerine artan g\u00f6\u00e7 yetene\u011fi ve apoptoza kar\u015f\u0131 diren\u00e7 kazand\u0131ran bir s\u00fcre\u00e7tir. Ya\u011f asidi elongaz ELOVL2, sfingomiyelin sentaz 2 (SGMS2) ve kemokin CXCL8 gibi molek\u00fcler d\u00fczenleyiciler, TGF-\u03b2, PI3K\/AKT ve SREBP sinyal a\u011flar\u0131n\u0131 etkinle\u015ftirerek gen ekspresyon programlar\u0131n\u0131 yeniden y\u00f6nlendirir ve h\u00fccreleri mezenkimal, invazif fenotipe kanalize eder.<\/p>\n
T\u00fcm\u00f6r ba\u011f\u0131\u015f\u0131kl\u0131k mikro\u00e7evresi (TIME), lipid kaynakl\u0131 sinyallere aktif bir yan\u0131t verir. \u0130mm\u00fcnosupresif M2 makrofajlar\u0131 ve kanser ili\u015fkili fibroblastlar (CAF’lar), lipid metabolizmalar\u0131n\u0131 yeniden programlayarak sitokin profillerini ve ekstrasell\u00fcler matriks bile\u015fenlerini t\u00fcm\u00f6r progresyonunu destekleyecek \u015fekilde de\u011fi\u015ftirirler. Ayn\u0131 zamanda, sitotoksik CD8+ T h\u00fccreleri lipid arac\u0131l\u0131 fonksiyonel bozulmaya u\u011frayarak anti-t\u00fcm\u00f6r ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n\u0131n zay\u0131flamas\u0131na ve ba\u011f\u0131\u015f\u0131kl\u0131k ka\u00e7\u0131\u015f mekanizmalar\u0131n\u0131n etkinle\u015fmesine katk\u0131 sa\u011flarlar.<\/p>\n
Klasik meme kanseri tedavilerine kar\u015f\u0131 diren\u00e7 mekanizmalar\u0131, lipid metabolizmas\u0131n\u0131n yeniden \u015fekillenmesi ile yak\u0131ndan ili\u015fkilidir. T\u00fcm\u00f6r h\u00fccreleri, CD36 gibi lipid ta\u015f\u0131y\u0131c\u0131lar\u0131n\u0131n, FASN gibi lipid sentez enzimlerinin ve CPT1 gibi mitokondriyal ya\u011f asidi oksidasyonu bile\u015fenlerinin ekspresyonunu art\u0131rarak apoptoz sinyallerini engeller ve ila\u00e7 birikimini azalt\u0131r. G protein-ba\u011flant\u0131l\u0131 resept\u00f6r 120 (GPR120) ise pro-survival lipid sinyallerini medyat\u00f6rl\u00fck ederek kanser k\u00f6k h\u00fccreli\u011finin korunmas\u0131na ve tedavi diren\u00e7lili\u011finin artmas\u0131na yol a\u00e7ar.<\/p>\n
Lipid metabolizmas\u0131 ile onkogenik sinyal yollar\u0131n\u0131n \u00e7apraz konu\u015fmas\u0131, meme kanserinde s\u00fcre\u00e7lerin karma\u015f\u0131kl\u0131\u011f\u0131n\u0131 art\u0131r\u0131r. SREBP1\/2 transkripsiyon fakt\u00f6rlerinin aktifle\u015fmesi, lipid biyosentezi ve al\u0131m\u0131n\u0131 d\u00fczenleyen genlerin ekspresyonunu kontrol ederek, TGF-\u03b2 ve PI3K\/AKT yollar\u0131 ile i\u015fbirli\u011fi i\u00e7inde malign fenotiplerin ortaya \u00e7\u0131kmas\u0131na neden olur. ELOVL2 enziminin azalmas\u0131 ise lipid dengesini bozarak EMT’yi ve metastatik yay\u0131l\u0131m\u0131 \u015fiddetlendirir, bu da metabolik enzimlerin h\u00fccresel plastikli\u011fe etkisini g\u00f6sterir.<\/p>\n
Kolesterol metabolitlerinin g\u00f6revleri t\u00fcm\u00f6r i\u00e7i i\u015flevlerin \u00f6tesine ge\u00e7er; 27HC, t\u00fcm\u00f6r \u00e7evresindeki ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerini mod\u00fcle ederek lokal imm\u00fcnosupresyon yarat\u0131r ve ba\u011f\u0131\u015f\u0131kl\u0131k g\u00f6zetiminden ka\u00e7\u0131\u015fa katk\u0131da bulunur. Bu dramatik etkile\u015fim, \u00f6zellikle hormon resept\u00f6r pozitif meme kanserlerinde \u00f6strojen sinyal yolaklar\u0131 ile lipid metabolizmas\u0131 aras\u0131ndaki ba\u011flant\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, tedavi stratejilerinde \u00f6nemli karma\u015f\u0131kl\u0131klar yaratmaktad\u0131r.<\/p>\n
Lipid metabolizmas\u0131na y\u00f6nelik geli\u015fen tedavi yakla\u015f\u0131mlar\u0131, ila\u00e7 direncini a\u015fmada umut vaat etmektedir. FASN inhibit\u00f6rleri, CD36 yoluyla ya\u011f asidi al\u0131m\u0131n\u0131 engelleyen ajanlar ve sfingolipid yolak d\u00fczenleyicileri, t\u00fcm\u00f6rlerin mevcut tedavilere kar\u015f\u0131 duyarl\u0131l\u0131\u011f\u0131n\u0131 art\u0131rmak amac\u0131yla ara\u015ft\u0131rma a\u015famas\u0131ndad\u0131r. Lipid metabolizmas\u0131n\u0131n hedeflendi\u011fi kombinasyon terapileri, klasik veya imm\u00fcn tabanl\u0131 tedavilerle birlikte kullan\u0131larak daha kal\u0131c\u0131 klinik yan\u0131tlar sa\u011flayabilir.<\/p>\n
\u00d6zetle, lipid metabolizmas\u0131n\u0131n yeniden programlanmas\u0131, meme kanseri ilerlemesini tetikleyen, metastatik yetenek kazand\u0131ran, ba\u011f\u0131\u015f\u0131kl\u0131k ka\u00e7\u0131\u015f\u0131n\u0131 destekleyen ve tedavi direncini art\u0131ran temel bir eksendir. Bu metabolik haritan\u0131n molek\u00fcler detaylar\u0131n\u0131n \u00e7\u00f6z\u00fclmesi, yeni biyobelirte\u00e7lerin ke\u015ffi ve metabolizmaya y\u00f6nelik tedavi se\u00e7eneklerinin geli\u015ftirilmesi i\u00e7in geni\u015f perspektifler a\u00e7maktad\u0131r. <\/p>\n
\u00d6zellikle TNBC gibi agresif alt tiplerde lipidomikle genomik ve proteomik verilerin entegre edilmesi, ki\u015fiselle\u015ftirilmi\u015f onkoloji yakla\u015f\u0131mlar\u0131n\u0131 daha da hassas hale getirecektir. Bu multidisipliner \u00e7al\u0131\u015fmalar, mekanistik ke\u015fiflerin klinik kazan\u0131mlara d\u00f6n\u00fc\u015fmesini sa\u011flayarak hastalar\u0131n sa\u011fkal\u0131m ve ya\u015fam kalitesini iyile\u015ftirme potansiyeli ta\u015f\u0131maktad\u0131r.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Lipid metabolizmas\u0131n\u0131n meme kanseri ilerlemesi ve tedavi direncindeki rol\u00fc, \u00f6zellikle \u00fc\u00e7l\u00fc negatif meme kanserinde metabolik yeniden programlama mekanizmalar\u0131.<\/p>\n Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Lipid metabolism involved in progression and drug resistance of breast cancer.<\/p>\n Web References<\/strong>: http:\/\/dx.doi.org\/10.1016\/j.gendis.2024.101376<\/p>\n Doi Referans<\/strong>: 10.1016\/j.gendis.2024.101376<\/p>\n Resim Credits<\/strong>: Genes & Diseases<\/p>\n Anahtar Kelimeler<\/strong>: Meme kanseri, lipid metabolizmas\u0131, ya\u011f asitleri, kolesterol, sfingolipidler, epitel-mezenkimal ge\u00e7i\u015f, ila\u00e7 direnci, t\u00fcm\u00f6r mikro\u00e7evresi, \u00fc\u00e7l\u00fc negatif meme kanseri, FASN, CD36, 27-hidroksikolesterol<\/p>\n","protected":false},"excerpt":{"rendered":" Kanser biyolojisindeki son geli\u015fmeler, meme kanseri h\u00fccrelerinin malign fenotiplerini s\u00fcrd\u00fcrmek i\u00e7in ger\u00e7ekle\u015ftirdi\u011fi karma\u015f\u0131k metabolik adaptasyonlar\u0131 anlamada \u00f6nemli ilerlemeler sa\u011flam\u0131\u015ft\u0131r. Bu adaptasyonlar aras\u0131nda lipid metabolizmas\u0131ndaki de\u011fi\u015fiklikler, t\u00fcm\u00f6r b\u00fcy\u00fcmesi, metastaz ve tedaviye yan\u0131t \u00fczerinde kritik bir rol oynamaktad\u0131r. \u00d6zellikle, agresif bir alt t\u00fcr olan \u00fc\u00e7l\u00fc negatif meme kanserinde (TNBC) lipid yolaklar\u0131n\u0131n yeniden programlanmas\u0131, kanser ilerlemesini engellemek ve…<\/p>\n","protected":false},"author":1,"featured_media":3382,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[2010,2006,2008,2009,2007],"tmauthors":[],"class_list":{"0":"post-3381","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-epitel-mezenkimal-gecis-ve-lipid-metabolizmasi","9":"tag-lipid-metabolizmasi-ve-meme-kanseri-progresyonu","10":"tag-meme-kanserinde-kolesterol-metabolizmasi","11":"tag-sfingolipidlerin-meme-kanseri-rolu","12":"tag-uclu-negatif-meme-kanserinde-lipid-yolaklari"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Lipid-Metabolizmasinin-Meme-Kanseri-Progresyonundaki-Rolu-1745251169.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3381"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3381\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3382"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3381"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}